Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Fulgent Genetics, |
RCV002491520 | SCV002800158 | uncertain significance | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2021-09-15 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV005384958 | SCV006044885 | uncertain significance | Cardiovascular phenotype | 2024-12-13 | criteria provided, single submitter | clinical testing | The p.G1122V variant (also known as c.3365G>T), located in coding exon 22 of the APOB gene, results from a G to T substitution at nucleotide position 3365. The glycine at codon 1122 is replaced by valine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |